img

Global Musculoskeletal Disorders Therapeutics Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034


Published on: 2024-01-04 | No of Pages : 320 | Industry : Medical Care

Publisher : GRD Survey | Format : PDF

Global Musculoskeletal Disorders Therapeutics Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global Musculoskeletal Disorders Therapeutics market is estimated at million US$ in 2021 and is expected to million US$ by the end of 2028, growing at a CAGR of % in the forecast period from 2022 to 2028.

This report studies the Musculoskeletal Disorders Therapeutics market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Musculoskeletal Disorders Therapeutics in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Biologics
Small Molecules

Market Snapshot, By Application
Osteoarthritis
Osteoporosis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia

Main Market Players Analyzed in this report, including
Zosano Pharma
Takeda
Taisho Pharmaceutical
Sanofi
Samsung Bioepis
Pfizer
Novartis
Merck
LG Life Sciences
Johnson & Johnson
F. Hoffmann-La Roche
Eli Lilly
AstraZeneca
Astellas
Amgen
AbbVie
AB Sciences
3SBio

The study objectives of this report are
To study and analyze the global Musculoskeletal Disorders Therapeutics market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Musculoskeletal Disorders Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Musculoskeletal Disorders Therapeutics manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Musculoskeletal Disorders Therapeutics market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Musculoskeletal Disorders Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Musculoskeletal Disorders Therapeutics are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Musculoskeletal Disorders Therapeutics Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Musculoskeletal Disorders Therapeutics Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Musculoskeletal Disorders Therapeutics

3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Osteoarthritis
3.2.2 Major Buyers in Osteoporosis

4 Market Segment: by Type
4.1 Musculoskeletal Disorders Therapeutics Type Introduction
4.1.1 Biologics
4.1.2 Small Molecules
4.2 Global Musculoskeletal Disorders Therapeutics Revenue by Type 2016-2021

5 Market Segment: by Application
5.1 Musculoskeletal Disorders Therapeutics Type Introduction
5.1.1 Osteoarthritis
5.1.2 Osteoporosis
5.1.3 Psoriatic Arthritis
5.1.3 Ankylosing Spondylitis
5.1.4 Fibromyalgia
5.2 Global Musculoskeletal Disorders Therapeutics Revenue by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Musculoskeletal Disorders Therapeutics Market by Region
6.2 North America Musculoskeletal Disorders Therapeutics Market 2016-2021
6.3 Europe Musculoskeletal Disorders Therapeutics Market 2016-2021
6.4 Asia Pacific Musculoskeletal Disorders Therapeutics Market 2016-2021
6.5 South America Musculoskeletal Disorders Therapeutics Market 2016-2021
6.6 Middle East and Africa Musculoskeletal Disorders Therapeutics Market 2016-2021

7 North America
7.1 North America Musculoskeletal Disorders Therapeutics Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Musculoskeletal Disorders Therapeutics Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Musculoskeletal Disorders Therapeutics Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Musculoskeletal Disorders Therapeutics Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Musculoskeletal Disorders Therapeutics Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Zosano Pharma
12.1.1 Zosano Pharma Company Information
12.1.2 Zosano Pharma Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
12.1.3 Zosano Pharma Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
12.1.4 Zosano Pharma Key Development
12.2 Takeda
12.2.1 Takeda Company Information
12.2.2 Takeda Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
12.2.3 Takeda Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
12.2.4 Takeda Key Development
12.3 Taisho Pharmaceutical
12.3.1 Taisho Pharmaceutical Company Information
12.3.2 Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
12.3.3 Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
12.3.4 Taisho Pharmaceutical Key Development
12.4 Sanofi
12.4.1 Sanofi Company Information
12.4.2 Sanofi Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
12.4.3 Sanofi Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
12.4.4 Sanofi Key Development
12.5 Samsung Bioepis
12.5.1 Samsung Bioepis Company Information
12.5.2 Samsung Bioepis Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
12.5.3 Samsung Bioepis Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
12.5.4 Samsung Bioepis Key Development
12.6 Pfizer
12.6.1 Pfizer Company Information
12.6.2 Pfizer Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
12.6.3 Pfizer Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
12.6.4 Pfizer Key Development
12.7 Novartis
12.7.1 Novartis Company Information
12.7.2 Novartis Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
12.7.3 Novartis Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
12.7.4 Pfizer Key Development
12.9 LG Life Sciences
12.9.1 LG Life Sciences Company Information
12.9.2 LG Life Sciences Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
12.9.3 LG Life Sciences Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
12.9.4 LG Life Sciences Key Development
12.8 Merck
12.8.1 Merck Company Information
12.8.2 Merck Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
12.8.3 Merck Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
12.8.4 Merck Key Development
12.11 F. Hoffmann-La Roche
12.11.1 F. Hoffmann-La Roche Company Information
12.11.2 F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
12.11.3 F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
12.11.4 F. Hoffmann-La Roche Key Development
12.12 Eli Lilly
12.12.1 Eli Lilly Company Information
12.12.2 Eli Lilly Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
12.12.3 Eli Lilly Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
12.12.4 Eli Lilly Key Development
12.13 AstraZeneca
12.13.1 AstraZeneca Company Information
12.13.2 AstraZeneca Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
12.13.3 AstraZeneca Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
12.13.4 AstraZeneca Key Development
12.14 Astellas
12.14.1 Astellas Company Information
12.14.2 Astellas Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
12.14.3 Astellas Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
12.14.4 Astellas Key Development
12.15 Amgen
12.15.1 Amgen Company Information
12.15.2 Amgen Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
12.15.3 Amgen Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
12.15.4 Amgen Key Development
12.17 AB Sciences
12.18 3SBio

13 Global Musculoskeletal Disorders Therapeutics Market Forecast by Region by Type and by Application
13.1 Global Musculoskeletal Disorders Therapeutics Revenue Forecast 2022-2027
13.2 Global Musculoskeletal Disorders Therapeutics Forecast by Regions
13.3 Global Musculoskeletal Disorders Therapeutics Forecast by Type
13.4 Global Musculoskeletal Disorders Therapeutics Forecast by Application

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer

List of Figure

List of Tables

Table 1: Global Musculoskeletal Disorders Therapeutics Production Specifications
Table 2: Drivers in Musculoskeletal Disorders Therapeutics Market
Table 3: Restraints Musculoskeletal Disorders Therapeutics Market
Table 4: Opportunity in Musculoskeletal Disorders Therapeutics Market
Table 5: Comparion of Alternative and Musculoskeletal Disorders Therapeutics
Table 6: Musculoskeletal Disorders Therapeutics Raw Materials Key Suppliers List
Table 7: Musculoskeletal Disorders Therapeutics Distributors List
Table 8: Musculoskeletal Disorders Therapeutics Major Buyers in Application One
Table 9: Musculoskeletal Disorders Therapeutics Major Buyers in Application Two
Table 10: Musculoskeletal Disorders Therapeutics Major Buyers in Application Three
Table 11: Global Musculoskeletal Disorders Therapeutics Revenue (Million USD) by Type 2016-2021
Table 12: Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Type 2016-2021
Table 18: Global Musculoskeletal Disorders Therapeutics Revenue (Million USD) by Application 2016-2021
Table 19: Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Application 2016-2021
Table 20: Global Musculoskeletal Disorders Therapeutics Revenue (Million USD) by Region 2016-2021
Table 21: Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Region 2016-2021
Table 22: North America Musculoskeletal Disorders Therapeutics Revenue (Million USD) by Country 2016-2021
Table 23: North America Musculoskeletal Disorders Therapeutics Revenue Market Share by Country 2016-2021)
Table 24: Europe Musculoskeletal Disorders Therapeutics Revenue (Million USD) by Country 2016-2021
Table 25: Europe Musculoskeletal Disorders Therapeutics Revenue Market Share by Country 2016-2021)
Table 26: Asia Pacific Musculoskeletal Disorders Therapeutics Revenue (Million USD) by Country 2016-2021
Table 27: Asia Pacific Musculoskeletal Disorders Therapeutics Revenue Market Share by Country 2016-2021)
Table 28: South America Musculoskeletal Disorders Therapeutics Revenue (Million USD) by Country 2016-2021
Table 29: South America Musculoskeletal Disorders Therapeutics Revenue Market Share by Country 2016-2021)
Table 30: Middle East and Africa Musculoskeletal Disorders Therapeutics Revenue (Million USD) by Country 2016-2021
Table 31: Middle East and Africa Musculoskeletal Disorders Therapeutics Revenue Market Share by Country 2016-2021)
Table 32 Zosano Pharma Company Information
Table 33 Zosano Pharma Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
Table 34 Zosano Pharma Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
Table 35 Takeda Company Information
Table 36 Takeda Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
Table 37 Takeda Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
Table 38 Taisho Pharmaceutical Company Information
Table 39 Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
Table 40 Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
Table 41 Sanofi Company Information
Table 42 Sanofi Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
Table 43 Sanofi Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
Table 44 Samsung Bioepis Company Information
Table 45 Samsung Bioepis Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
Table 46 Samsung Bioepis Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
Table 47 Pfizer Company Information
Table 48 Pfizer Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
Table 49 Pfizer Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
Table 50 Novartis Company Information
Table 51 Novartis Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
Table 52 Novartis Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
Table 53 Merck Company Information
Table 54 Merck Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
Table 55 Merck Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
Table 56 LG Life Sciences Company Information
Table 57 LG Life Sciences Musculoskeletal Disorders Therapeutics Product Portfolio, Specification and Application
Table 58 LG Life Sciences Musculoskeletal Disorders Therapeutics Revenue and Gross Margin (2019-2021)
Table 59: Global Musculoskeletal Disorders Therapeutics Revenue (Million USD) Forecast by Region (2022-2027)
Table 60: Global Musculoskeletal Disorders Therapeutics Revenue Market Share Forecast by Region (2022-2027)
Table 61: Global Musculoskeletal Disorders Therapeutics Revenue (Million USD) Forecast by Type (2022-2027)
Table 62: Global Musculoskeletal Disorders Therapeutics Revenue Market Share Forecast by Type (2022-2027)
Table 63: Global Musculoskeletal Disorders Therapeutics Revenue (Million USD) Forecast by Application (2022-2027)
Table 64: Global Musculoskeletal Disorders Therapeutics Revenue Market Share Forecast by Application (2022-2027)


List of Figures

Figure 1: Musculoskeletal Disorders Therapeutics Picture
Figure 2: Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Musculoskeletal Disorders Therapeutics Industry Life Cycle
Figure 5: Product Picture of Biologics
Figure 6: Product Picture of Small Molecules
Figure 9: Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Type, 2020
Figure 10: Musculoskeletal Disorders Therapeutics in Osteoarthritis
Figure 11: Global Musculoskeletal Disorders Therapeutics Market: Osteoarthritis 2016-2021
Figure 12: Musculoskeletal Disorders Therapeutics in Osteoporosis
Figure 13: Global Musculoskeletal Disorders Therapeutics Market: Osteoporosis 2016-2021
Figure 14: Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Application, 2020
Figure 15: Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Region 2016-2021
Figure 16: North America Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 7: Europe Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 8: Asia Pacific Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 9: South America Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 10: Middle East and Africa Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 11: North America Musculoskeletal Disorders Therapeutics Revenue Market Share by Country, 2020
Figure 12: United States Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 13: Canada Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 14: Mexico Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 15: Europe Musculoskeletal Disorders Therapeutics Revenue Market Share by Country, 2020
Figure 16: Germany Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 17: France Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 18: UK Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 19: Italy Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 20: Russia Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 21: Spain Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Musculoskeletal Disorders Therapeutics Revenue Market Share by Country, 2020
Figure 23: China Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 24: Japan Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 25: Korea Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 26: Southeast Asia Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 27: India Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 28: Australia Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 29: South America Musculoskeletal Disorders Therapeutics Revenue Market Share by Country, 2020
Figure 30: Brazil Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 31: Argentina Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 32: Colombia Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 33: Middle East and Africa Musculoskeletal Disorders Therapeutics Revenue Market Share by Country, 2020
Figure 34: Turkey Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 35: Saudi Arabia Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 36: South Africa Musculoskeletal Disorders Therapeutics Revenue (Million USD) Status 2016-2021
Figure 37: Zosano Pharma Musculoskeletal Disorders Therapeutics Revenue Market Share Globally (2019-2021)
Figure 38: Takeda Musculoskeletal Disorders Therapeutics Revenue Market Share Globally (2019-2021)
Figure 39: Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Revenue Market Share Globally (2019-2021)
Figure 40: Sanofi Musculoskeletal Disorders Therapeutics Revenue Market Share Globally (2019-2021)
Figure 41: Samsung Bioepis Musculoskeletal Disorders Therapeutics Revenue Market Share Globally (2019-2021)
Figure 42: Pfizer Musculoskeletal Disorders Therapeutics Revenue Market Share Globally (2019-2021)
Figure 43: Novartis Musculoskeletal Disorders Therapeutics Revenue Market Share Globally (2019-2021)
Figure 44: Merck Musculoskeletal Disorders Therapeutics Revenue Market Share Globally (2019-2021)
Figure 45: LG Life Sciences Musculoskeletal Disorders Therapeutics Revenue Market Share Globally (2019-2021)
Figure 46: Johnson & Johnson Musculoskeletal Disorders Therapeutics Revenue Market Share Globally (2019-2021)
Figure 47: Global Musculoskeletal Disorders Therapeutics Revenue (Million USD) Forecast (2022-2027)